賴氨酰氧化酶(LOX)活性蛋白
Active Lysyl Oxidase (LOX)
Protein-Lysine 6-Oxidase
- 編號APC580Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 90%
- 等電點6.2
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1728 ¥ 4320 ¥ 8640 ¥ 25920 ¥ 64800
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實驗
Lysyl oxidase (LOX) also known as protein-lysine 6-oxidase is an extracellular copper-dependent enzyme that catalyzes formation of aldehydes from lysine residues in collagen and elastin precursors. Its catalytic activity depends upon both its copper cofactor and a unique carbonyl cofactor and has been shown to extend to a variety of basic globular proteins, including histone H1. LOX plays a major role in connective tissue development and may also be important in neurological function. Lysyl oxidase has also proven crucial to the development of the respiratory system and the skin, the commitment step of adipocyte, and the formation of pluripotent stem cells during development. Its absence may lead to defects in the transforming growth factor beta superfamily of proteins, which control cell growth and differentiation. Besides, Elastin (ELN) has been identified as an interactor of LOX, thus a binding ELISA assay was conducted to detect the interaction of recombinant human LOX and recombinant human ELN. Briefly, LOX were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100uL were then transferred to ELN-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-LOX pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of LOX and ELN was shown in Figure 1, and this effect was in a dose dependent manner.
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APC580Hu01 | 賴氨酰氧化酶(LOX)活性蛋白 | Cell?culture;?Activity?Assays. |
RPC580Hu01 | 賴氨酰氧化酶(LOX)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC580Hu02 | 賴氨酰氧化酶(LOX)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPC580Hu61 | 賴氨酰氧化酶(LOX)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC580Hu02 | 賴氨酰氧化酶(LOX)多克隆抗體 | WB; IHC; ICC; IP. |
PAC580Hu01 | 賴氨酰氧化酶(LOX)多克隆抗體 | WB; IHC; ICC; IP. |
LAC580Hu81 | 賴氨酰氧化酶(LOX)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
LAC580Hu71 | 賴氨酰氧化酶(LOX)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAC580Hu22 | 賴氨酰氧化酶(LOX)單克隆抗體 | WB; IHC; ICC; IP. |
SEC580Hu | 賴氨酰氧化酶(LOX)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
WEC580Hu | 賴氨酰氧化酶(LOX)檢測試劑盒(酶聯(lián)免疫吸附試驗法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC580Hu | 賴氨酰氧化酶(LOX)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSC580Hu01 | 賴氨酰氧化酶(LOX)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | 自己動手制作ELISA試劑盒的主要材料 |
參考文獻
雜志 | 參考文獻 |
American Journal of Hematology | The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms. [PubMed: 23494965] |
Current Eye Research | High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells [Pubmed: 22966818] |
European Journal of Surgical Oncology | Evaluation of serum lysyl oxidase as a blood test for colorectal cancer [Pubmed: 24246612] |
Vaccine | Copia autorizada por CDR [Ingentaconnect: Source] |
Arthritis & Rheumatology | Lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis [Pubmed: 24574233] |
Eur J Surg Oncol.? | Evaluation of serum lysyl oxidase as a blood test for colorectal cancer [Pubmed:Pmc4237001] |
BMC Cancer. | Ionizing radiation induces tumor cell lysyl oxidase secretion [Pubmed:Pmc4223762] |
DNA Cell Biol. | Lysyl Oxidase Genetic Variants Affect Gene Expression in Cervical Cancer [Pubmed:24945327] |
scandinavian journal of immunology | Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis [PubMed: 26095613] |
Curr Eye Res | Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-? Levels and LOXL1 Genotype in Pseudoexfoliation [Pubmed:27116380] |
journal of bone and mineral metabolism | LOX Fails to Substitute for RANKL in Osteoclastogenesis. [pubmed:27606829] |
38 | Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases. [pubmed:28445728] |
Molecular Medicine Reports | Lysyl oxidase is involved in synovial hyperplasia and angiogenesis in rats with collagen?induced arthritis [pubmed:28901438] |
Revista Espa?ola de Cardiología?(English?Edition) | A Global Assessment of Circulating Prolysyl Oxidase in Nonischemic Patients With Garden-variety Heart Failure With Preserved Ejection Fraction [Pubmed:29807761] |
Molecular?Medicine?Reports | Lysyl oxidase inhibition via β-aminoproprionitrile hampers human umbilical vein endothelial cell angiogenesis and migration in vitro [Pubmed:29393489] |
Thyroid | Lysyl Oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness [Pubmed: 30398411] |
Am J Physiol Lung Cell Mol Physiol | Lysyl Oxidase Directly Contributes to Extracellular Matrix Production and Fibrosis in Systemic Sclerosis. [Pubmed: 33026236] |
J Am Heart Assoc | Collagen Cross?\Linking Is Associated With Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy [33356379] |